| Die meistzitierten Artikel | Die meistzitierten Reviews | Die meistzitierten Köpfe |
Bild der meistzitierten Köpfe |
||
Die meistzitierten Artikel |
|||
| Rang | Autoren | Paper | Zitierungen |
| 1. | Spanagel R, ..., Zghoul T, Sanchis-Segura C, ..., Lascorz J, Depner M, ..., Schumann G, Albrecht U. | The clock gene Per2 influences the glutamatergic system and modulates alcohol consumption. NAT MED 2005, 11(1):35-42 | 154 |
| 2. | Reif A, Fritzen S, Finger M, ..., Lauer M, Schmitt A, Lesch KP. | Neural stem cell proliferation is decreased in schizophrenia, but not in depression. MOL PSYCH 2006, 11(5):514-22 | 119 |
| 3. | Wendland JR, Martin BJ, Kruse MR, Lesch KP, Murphy DL. | Simultaneous genotyping of four functional loci of human SLC6A4, with a reappraisal of 5-HTTLPR and rs25531. MOL PSYCH 2006, 11(3):224-6 | 119 |
| 4. | Monory K, Massa F, ..., Kelsch W, Jacob W, Marsch R, ..., Wölfel B, Dodt HU, Zieglgänsberger W, Wotjak CT, ..., Marsicano G, Lutz B. | The endocannabinoid system controls key epileptogenic circuits in the hippocampus. NEURON 2006, 51(4):455-66 | 118 |
| 5. | Plath N, ..., Welzl H, ..., Lipp HP, ..., Wolfer DP, Kuhl D. | Arc/Arg3.1 is essential for the consolidation of synaptic plasticity and memories. NEURON 2006, 52(3):437-44 | 118 |
| 6. | Canli T, Omura K, Haas BW, Fallgatter A, Constable RT, Lesch KP. | Beyond affect: A role for genetic variation of the serotonin transporter in neural activation during a cognitive attention task. PNAS 2005, 102(34):12224-9 | 115 |
| 7. | Canli T, ..., Herrmann MJ, ..., Lesch KP. | Neural correlates of epigenesis. PNAS 2006, 103(43):16033-8 | 86 |
| 8. | Meyer U, Nyffeler M, ..., Schedlowski M, Knuesel I, Yee BK, Feldon J. | The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. J NEUROSCI 2006, 26(18):4752-62 | 86 |
| 9. | Ridder S, Chourbaji S, Hellweg R, Urani A, Zacher C, ..., Zink M, Hörtnagl H, Flor H, Henn FA, ..., Gass P. | Mice with genetically altered glucocorticoid receptor expression show altered sensitivity for stress-induced depressive reactions. J NEUROSCI 2005, 25(26):6243-50 | 84 |
| 10. | Canli T, ..., Gutknecht L, ..., Lesch KP. | Amygdala responsiveness is modulated by tryptophan hydroxylase-2 gene variation. J NEURAL TRANSM 2005, 112(11):1479-85 | 80 |
Die meistzitierten Reviews |
|||
| Rang | Autoren | Paper | Zitierungen |
| 1. | Cryan JF, Valentino RJ, Lucki I. | Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. NEUROSCI BIOBEH REV 2005, 29(4-5):547-69 | 219 |
| 2. | Cryan JF, Holmes A. | The ascent of mouse: Advances in modelling human depression and anxiety. NAT REV DRUG DISCOV 2005, 4(9):775-90 | 206 |
| 3. | Cryan JF, Mombereau C, Vassout A. | The tail suspension test as a model for assessing antidepressant activity: Review of pharmacological and genetic studies in mice. NEUROSCI BIOBEH REV 2005, 29(4-5):571-625 | 168 |
| 4. | Rudolph U, Möhler H. | GABA-based therapeutic approaches: GABA(A) receptor subtype functions. CURR OPIN PHARMACOL 2005, 6(1):18-23 | 116 |
Die meistzitierten Köpfe |
||||
| Rang | Name | Ort | Zitierungen | Artikel |
| 1. | Klaus P. Lesch | Psychobiol., Psychiatrie, Uniklinik Würzburg | 1871 | 80 |
| 2. | Beat Lutz | Physiol. Chem., Uni Mainz (bis 2005 München) | 1432 | 42 |
| 3. | Andreas Zimmer | Mol. Psych., & Mol. Neurobiol., Uni Bonn | 1165 | 39 |
| 4. | Giovanni Marsicano | MPI Psych., München (seit 2006 Bordeaux) | 1146 | 29 |
| 5. | Joram Feldon | Verh.neurobiol., ETH Zürich, Schwerzenbach | 1126 | 70 |
| 6. | Wojciech Danysz | Preklin. R&D, Merz Pharmac. GmbH, Frankfurt | 769 | 39 |
| 7. | Benjamin K. Yee | Verh.neurobiol., ETH Zürich, Schwerzenbach | 756 | 36 |
| 8. | Rainer Spanagel | Psychopharmakol., ZI Mannheim (bis 2005 München) | 717 | 36 |
| 9. | John F. Cryan | Neuro. Res., Novartis Basel (seit 2006 Cork, Irland) | 698 | 34 |
| 10. | Krisztina Monory | Physiol. Chem., Uni Mainz (bis 2005 München) | 680 | 13 |
| 11. | Inga D. Neumann | Verh.neuroendokrinol., Uni Regensburg | 617 | 27 |
| 12. | Carsten T. Wotjak | Mausverh., MPI Psychiatrie München | 562 | 21 |
| 13. | Manfred Schedlowski | Med. Psych. & Verh.immun., Uni Duisburg-Essen | 555 | 43 |
| 14. | Hans-Peter Lipp | Neuroanat. & Verh., Zentr. Neurowiss., Uni Zürich | 544 | 29 |
| 15. | Rolf Sprengel | Mol. Neurobiol., MPI Med. Forschung Heidelberg | 515 | 28 |
| 16. | Joseph P. Huston | bis 2007 Physiol. Psychol., Uni Düsseldorf | 467 | 44 |
| 17. | David P. Wolfer | Neuroanat. & Verh., Uni Zürich | 451 | 18 |
| 18. | Eberhard Fuchs | Klin. Neurobiol., DPZ Göttingen | 434 | 28 |
| 19. | Randolf Menzel | Neurobiol., FU Berlin | 428 | 24 |
| 20. | Rainer Landgraf | Verh.neuroendokrinol., MPI Psychiatrie München | 425 | 23 |
| 21. | Peter Gass | Verh.biol., ZI Seel. Gesundh. Mannheim, Uni Heidelberg | 415 | 26 |
| 22. | Nicolas Singewald | Pharmakol. & Toxikol., CMBI Uni Innsbruck | 400 | 27 |
| 23. | Rainer Rupprecht | Neuropsychopharmakol., Psychiatrie, LMU München | 385 | 35 |
| 24. | Carles Sanchis-Segura | Psychopharmakol., ZI Mannheim | 376 | 16 |
| 25. | Uwe Rudolph | Pharmakol. & Toxikol., Uni Zürich (seit 2006 USA) | 372 | 21 |
| 26. | Walter Zieglgänsberger | Klin. Neuropharmakol., MPI Psych. München | 368 | 19 |
| 27. | Hanns Möhler | Pharmakol. & Toxikol., Uni Zürich & ETH Zürich | 354 | 12 |
| 28. | Klemens Kaupmann | TA Nervensystem, Novartis Pharma AG Basel | 339 | 19 |
| 29. | Herman van der Putten | TA Nervensystem, Novartis Pharma AG Basel | 334 | 14 |
| 30. | Oliver J. Bosch | Zoologie, Uni Regensburg | 323 | 11 |
| 31. | Onur Güntürkün | Biopsychologie, Uni Bochum | 311 | 37 |
| 32. | Irene Knuesel | Verh.neurobiol., ETH Zürich, Schwerzenbach | 298 | 10 |
| 33. | Urs Meyer | Verh.neurobiol., ETH Zürich, Schwerzenbach | 284 | 10 |
| 34. | Michael Koch | Neuropharmakol., Inst.Hirnforsch., Uni Bremen | 272 | 26 |
| 35. | Markus Fendt | Tierphysiol., Uni Tübingen | 259 | 22 |
| 36. | Martin Heisenberg | Gen. & Neurobiol., Biozentrum Uni Würzburg | 255 | 12 |
| 37. | Myriel Nyffeler | Verh.neurobiol., ETH Zürich, Schwerzenbach | 250 | 7 |
| 38. | Sabine Chourbaji | Verh.biol. Maus, ZI Mannheim | 250 | 16 |
| 39. | C. Giovanni Galizia | Neurobiol., Uni Konstanz | 240 | 12 |
| 40. | Wolfgang Froestl | TA Nervensystem, Novartis Pharma AG Basel | 240 | 16 |
| 41. | Gabriele Flügge | Klin. Neurobiol. Labor, DPZ Göttingen | 236 | 13 |
| 42. | Rainer K. W. Schwarting | Exp. & Physiol. Psychol., Uni Marburg | 236 | 22 |
| 43. | Will P. J. M. Spooren | TA Nervensystem, Novartis Pharma AG Basel | 235 | 15 |
| 44. | Lise Gutknecht | Psychobiol., Psychiatrie, Uniklinik Würzburg | 234 | 9 |
| 45. | Marianne B. Müller | Mol. Stressphysiol., MPI Psych. München | 230 | 18 |
| 46. | Werner J. Schmidt † | Neuropharmakol., Zool., Uni Tübingen | 223 | 25 |
| 47. | A. Katharina Braun | Biologie, Uni Magdeburg | 217 | 26 |
| 48. | Boldizsár Czéh | Klin. Neurobiol. Labor, DPZ Göttingen | 213 | 15 |
| 49. | Fabrizio Gasparini | TA Nervensystem, Novartis Pharma AG Basel | 205 | 15 |
| 50. | Gisela Grecksch | Pharmakol. & Toxikol., Uni Magdeburg | 202 | 15 |
